Fludarabine and busulfan (FluBuP regimen) as myeloablative conditioning regimen for allogeneic PBSCT in 71 leukemic patients (A unicenteric study).

被引：0
|
作者：
Iravani, M [1 ]
Tavakoli, M [1 ]
Shamshiri, AR [1 ]
Evazi, MR [1 ]
Mousavi, A [1 ]
Bahar, B [1 ]
Ghavamzadeh, A [1 ]
机构：
[1] Univ Tehran Med Sci, Shariati Hosp, Hematol Oncol & BMT Res Ctr, Tehran, Iran
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.5156.5156
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5156
引用
收藏
页码：373B / 373B
页数：1
相关论文
共 50 条
  • [1] One year follow up of 71 leukemic patients who received fludarabine and busulfan (FLUBUP) as myeloablative conditioning regimen for allogeneic PBSCT
    Iravani, M
    Tavakoli, M
    Shamshiri, AR
    Mousavi, A
    Bahar, B
    Ghavamzadeh, A
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 21 - 21
  • [2] Fludarabine and busulfan (FluBu regimen) as myeloablative conditioning regimen for allogeneic PBSCT in 71 leukaemic patients (a single centre study)
    Iravani, M
    Tavakoli, M
    Shamshiri, AR
    Evazi, MR
    Mousavi, A
    Bahar, B
    Ghavamzadeh, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S218 - S219
  • [3] Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients
    Iravani, M.
    Evazi, M. R.
    Mousavi, S. A.
    Shamshiri, A. R.
    Tavakoli, M.
    Ashouri, A.
    Samiee, S.
    Chahardovali, B.
    Alimoghaddam, K.
    Ghaffari, S. H.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2007, 40 (02) : 105 - 110
  • [4] Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients
    M Iravani
    M R Evazi
    S A Mousavi
    A R Shamshiri
    M Tavakoli
    A Ashouri
    S Samiee
    B Chahardovali
    K Alimoghaddam
    S H Ghaffari
    A Ghavamzadeh
    Bone Marrow Transplantation, 2007, 40 : 105 - 110
  • [5] Efficacy of treosulfan in combination with fludarabine as conditioning regimen in allogeneic transplantation as compared with a myeloablative conditioning using busulfan and fludarabine
    Calvo Sanchez, J. A.
    Fernandez Garcia, S.
    Aranguren del Castillo, L.
    Fernandez-Luis, S.
    Yanez San Segundo, L.
    Insunza Gaminde, A.
    Fernandez Escalada, N.
    Martin Sanchez, G.
    Colorado Araujo, M. M.
    Lopez Duarte, M.
    Sanchez Escamilla, M.
    Montes Gaisan, C.
    Romon Alonso, J. I.
    Arroyo Rodriguez, J. L.
    Ocio San Miguel, E. M.
    Bermudez Rodriguez, M. A.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 166 - 167
  • [6] Myeloablative conditioning with fludarabine and busulfan for allogeneic PBSCT in chronic phase CML
    Iravani, M
    Tavakoli, M
    Shamshiri, AR
    Mousavi, A
    Bahar, B
    Jahani, M
    Ghavamzadeh, A
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 22 - 22
  • [7] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Sohn, S. K.
    Chae, Y. S.
    Kim, J. G.
    Cho, Y. Y.
    Moon, J. H.
    Shin, H. J.
    Chung, J. S.
    Cho, G. J.
    Yang, D. H.
    Lee, J. J.
    Kim, Y. K.
    Kim, H. J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S203 - S204
  • [8] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Chae, Y. S.
    Sohn, S. K.
    Kim, J. G.
    Cho, Y. Y.
    Moon, J. H.
    Shin, H. J.
    Chung, J. S.
    Cho, G. J.
    Yang, D. H.
    Lee, J-J
    Kim, Y-K
    Kim, H-J
    BONE MARROW TRANSPLANTATION, 2007, 40 (06) : 541 - 547
  • [9] Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients
    Dai, Zhiming
    Liu, Jie
    Zhang, Wang-Gang
    Cao, Xingmei
    Zhang, Yang
    Dai, Zhijun
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) : 667 - 671
  • [10] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Y S Chae
    S K Sohn
    J G Kim
    Y Y Cho
    J H Moon
    H J Shin
    J S Chung
    G J Cho
    D H Yang
    J-J Lee
    Y-K Kim
    H-J Kim
    Bone Marrow Transplantation, 2007, 40 : 541 - 547
12345